Bleakley Financial Group, LLC Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$3.2T
Holdings
926
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (926 positions)
| Stock | Value |
|---|---|
POWWAMMO INC | $54.8M |
PGENPRECIGEN INC | $49.7M |
OLPXOLAPLEX HLDGS INC | $43.9M |
ADMAADMA BIOLOGICS INC | $40.7M |
MPLNUSDMULTIPLAN CORPORATION | $40.1M |
COMPCOMPASS INC | $37.4M |
5TCTRUECAR INC | $36.4M |
KK0NEXTNAV INC | $36.0M |
DNAGINKGO BIOWORKS HOLDINGS INC | $30.6M |
KPTIEURKARYOPHARM THERAPEUTICS INC | $28.6M |
—CANO HEALTH INC | $25.6M |
TDAYGANNETT CO INC | $24.7M |
LUMNLUMEN TECHNOLOGIES INC | $24.4M |
—WEWORK INC | $22.2M |
NKTXNKARTA INC | $22.2M |
MTNBEURMATINAS BIOPHARMA HLDGS INC | $21.6M |
—CHARGE ENTERPRISES INC | $20.1M |
CXDOCREXENDO INC | $19.4M |
GWHESS TECH INC | $15.9M |
NYMXFNYMOX PHARMACEUTICAL CORP | $15.2M |
—META MATERIALS INC | $11.0M |
CLOVCLOVER HEALTH INVESTMENTS CO | $9.9M |
SCOR1EURCOMSCORE INC | $8.9M |
—PARTS ID INC | $8.3M |
FXLVF45 TRAINING HLDGS INC | $7.5M |
TCRTALAUNOS THERAPEUTICS INC | $7.4M |
PreviousPage 10 of 10